WO1999043807A3 - Human channel-related molecules - Google Patents

Human channel-related molecules Download PDF

Info

Publication number
WO1999043807A3
WO1999043807A3 PCT/US1999/002739 US9902739W WO9943807A3 WO 1999043807 A3 WO1999043807 A3 WO 1999043807A3 US 9902739 W US9902739 W US 9902739W WO 9943807 A3 WO9943807 A3 WO 9943807A3
Authority
WO
WIPO (PCT)
Prior art keywords
related molecules
human channel
hcrm
provides
expression
Prior art date
Application number
PCT/US1999/002739
Other languages
French (fr)
Other versions
WO1999043807A2 (en
Inventor
Olga Bandman
Henry Yue
Preeti Lal
Neil C Corley
Janice Au-Young
Y Tom Tang
Mariah R Baughn
Original Assignee
Incyte Pharma Inc
Olga Bandman
Henry Yue
Preeti Lal
Neil C Corley
Au Young Janice
Y Tom Tang
Mariah R Baughn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharma Inc, Olga Bandman, Henry Yue, Preeti Lal, Neil C Corley, Au Young Janice, Y Tom Tang, Mariah R Baughn filed Critical Incyte Pharma Inc
Priority to AU26649/99A priority Critical patent/AU2664999A/en
Priority to CA002321667A priority patent/CA2321667A1/en
Priority to EP99906827A priority patent/EP1056853A2/en
Priority to JP2000533547A priority patent/JP2002504368A/en
Publication of WO1999043807A2 publication Critical patent/WO1999043807A2/en
Publication of WO1999043807A3 publication Critical patent/WO1999043807A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides human channel-related molecules (HCRM) and polynucleotides which identify and encode HCRM. This invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HCRM.
PCT/US1999/002739 1998-02-25 1999-02-08 Human channel-related molecules WO1999043807A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU26649/99A AU2664999A (en) 1998-02-25 1999-02-08 Human channel-related molecules
CA002321667A CA2321667A1 (en) 1998-02-25 1999-02-08 Human channel-related molecules
EP99906827A EP1056853A2 (en) 1998-02-25 1999-02-08 Human channel-related molecules
JP2000533547A JP2002504368A (en) 1998-02-25 1999-02-08 Human channel-related molecules

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3074798A 1998-02-25 1998-02-25
US09/030,747 1998-02-25

Publications (2)

Publication Number Publication Date
WO1999043807A2 WO1999043807A2 (en) 1999-09-02
WO1999043807A3 true WO1999043807A3 (en) 1999-12-16

Family

ID=21855815

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/002739 WO1999043807A2 (en) 1998-02-25 1999-02-08 Human channel-related molecules

Country Status (5)

Country Link
EP (1) EP1056853A2 (en)
JP (1) JP2002504368A (en)
AU (1) AU2664999A (en)
CA (1) CA2321667A1 (en)
WO (1) WO1999043807A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054378A1 (en) * 2000-10-27 2002-05-02 Mannesmann Ag Procedure for collecting user fees
WO2008013816A2 (en) * 2006-07-24 2008-01-31 Thallion Pharmaceuticals, Incorporated Tat-051 and methods of assessing and treating cancer

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A. STRATMANN ET AL.: "Molecular cloning and issue expression of a cDNA encoding IP1-A P0-like glycoprotein of trout CNS myelin", JOURNAL OF NEUROCHEMISTRY, vol. 64, no. 6, June 1995 (1995-06-01), pages 2427 - 2436, XP002107131 *
Emest3 Database Entry AA781956 Accession number AA781956; 6 February 1998 *
JAMESEUBANKS ET AL.: "Structure and chromosomal localization of the beta2 subunit of the human brain sodium channel", NEUROREPORT, vol. 8, no. 12, 18 August 1997 (1997-08-18), pages 2775 - 2779, XP002107132 *
KUDO N ET AL: "Molecular cloning and cell cycle-dependent expression of mammalian CRM1, protein involved in nuclear export of proteins.", JOURNAL OF BIOLOGICAL CHEMISTRY, (1997 NOV 21) 272 (47) 29742-51. JOURNAL CODE: HIV. ISSN: 0021-9258., UNITED STATES, XP002107133 *
MARIA GUTTINGER ET AL.: "Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis", THE JOURNAL OF CELL BIOLOGY, vol. 141, no. 4, 18 May 1998 (1998-05-18), pages 1061 - 1071, XP002107134 *

Also Published As

Publication number Publication date
WO1999043807A2 (en) 1999-09-02
JP2002504368A (en) 2002-02-12
EP1056853A2 (en) 2000-12-06
AU2664999A (en) 1999-09-15
CA2321667A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
WO1999036550A3 (en) Human protease molecules
WO1999061471A3 (en) Human transmembrane proteins
WO2002046383A3 (en) Protein modification and maintenance molecules
WO2000015793A3 (en) Human gpcr proteins
WO2000034477A3 (en) Neuron-associated proteins
WO2000018922A3 (en) Human carbohydrate-associated proteins
WO1999058692A3 (en) Human apoptosis associated proteins
WO2000012711A8 (en) Human membrane channel proteins
WO1999057144A3 (en) Human transcriptional regulator molecules
WO2000012703A3 (en) Protein transport-associated molecules
WO2000017355A3 (en) Human cytoskeleton associated proteins
WO2000014251A3 (en) Human transferase proteins
WO2000005374A3 (en) Molecules associated with cell proliferation
WO2000000594A3 (en) Human transferases
WO2000020604A3 (en) Oxidoreductase molecules
WO2001032888A3 (en) Human transferase molecules
WO1999041373A3 (en) Human transport-associated molecules
WO1999038981A3 (en) Human protein kinase molecules
WO1999057270A3 (en) Human receptor molecules
WO2000028045A3 (en) Human hydrolase proteins
WO2004053068A3 (en) Protein modification and maintenance molecules
WO2003063688A3 (en) Protein modification and maintenance molecules
WO2004009797A3 (en) Protein modification and maintenance molecules
WO1999049037A3 (en) Protein phosphatase-related molecules
WO2000008155A3 (en) Human receptor-associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 533547

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref document number: 2321667

Country of ref document: CA

Ref country code: CA

Ref document number: 2321667

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999906827

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999906827

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999906827

Country of ref document: EP